AstraZeneca reported 8.94B in Gross Profit on Sales for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Abbvie ABBV:US $ 9517M 1089M
Alcon AG ALC:SW 1.21B 12M
Amgen AMGN:US $ 4677M 451M
AstraZeneca AZN:LN 8.94B 2.9B
Astrazeneca AZN:US 9.11B 169M
AstraZeneca AZN:SS 9.11B 169M
Bayer BAYN:GR 7.43B 1.54B
Biogen BIIB:US $ 1777.9M 295.8M
Bristol Myers Squibb BMY:US $ 9177M 452M
Eli Lilly And LLY:US $ 5737.9M 211.8M
Fresenius FRE:GR € 2712M 189M
Fresenius Medical Care FME:GR € 1319M 52M
Galapagos GLPG:NA 183.42M 106.98M
Gilead Sciences GILD:US $ 5166M 549M
GlaxoSmithKline GSK:LN 6.14B 283M
GRIFOLS GRF:SM € 580.8M 47.47M
H. Lundbeck A/S LUN:DC 3.53B 474M
Hikma Pharmaceutical HIK:LN 685M 69M
Lonza Group LONN:SW 1.07B 24M
Merck MRK:GR € 3211M 43M
Merk MRK:US $ 10567M 873M
Novartis NOVN:VX 9.52B 3M
Orion ORNBV:FH 153.6M 23M
Pfizer PFE:US $ 15651M 1516M
Philips PHIA:NA € 1918M 56M
Recordati REC:IM 278.29M 5.84M
Regeneron Pharmaceuticals REGN:US $ 2560.2M 1408.9M